Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Cancer mouse models and other techniques for improved prediction of efficacy.
Kiselyov
Alex
A
ChemDiv Inc, Suite 5, San Diego, CA 92121, USA. ask@chemdiv.com
D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D000818:Animals; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D005544:Forecasting; D049452:Green Fluorescent Proteins; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D000077146:Irinotecan; D008164:Luminescent Proteins; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D011719:Pyrazines / Q000627:therapeutic use; D013678:Technology, Pharmaceutical / Q000379:methods / Q000639:trends*; D016896:Treatment Outcome; D000093542:Gemcitabine; D000097573:Red Fluorescent Protein
D020533:Angiogenesis Inhibitors; D001897:Boronic Acids; D000069286:Bortezomib; D002166:Camptothecin; D003841:Deoxycytidine; D049452:Green Fluorescent Proteins; D000077146:Irinotecan; D008164:Luminescent Proteins; D011719:Pyrazines; D000093542:Gemcitabine; D000097573:Red Fluorescent Protein